Table 3 Asthma control, asthma medication and frequency of severe exacerbation in 12 months follow-up after discharge
Characteristic (n = 889) | N/% |
|---|---|
Economic income | |
Above the average PCDI | 323/36.33 |
Below the average PCDI | 566/63.67 |
Follow up regularly | 77/8.66 |
Frequency of pulmonary function test | 70/7.87 |
PFM utilization | 32/3.60 |
Writing in an asthma diary regularly | 47/5.29 |
Application of ICS/(ICS + LABA)/(ICS + LAMA) after hospital discharge | |
≤ 3 m | 547/61.53 |
3–6 m | 218/24.52 |
> 6 m | 124/13.95 |
Reasons for application of ICS/(ICS + LABA)/(ICS+ LAMA) ≤ 3 m (depend on the answer of patients) | |
The medicine was too expensive | 391/71.48 |
Incorrect inhaler technique | 55/10.05 |
Feel symptom was controlled | 255/46.62 |
Others | 64/11.70 |
Application of other asthma medicines | 408/45.89 |
Theophylline | 125/14.06 |
Leukotriene receptor antagonist | 204/22.95 |
OCS | 79/8.89 |
Other drugs (eg. Chinese traditional drugs) | 158/17.77 |
ACT scores (the mean value of one year follow-up) | |
≤ 15 | 281/31.61 |
16–20 | 358/40.27 |
21–25 | 250/28.12 |
Frequency of hospital and emergency room admissions in the follow-up | |
none | 401/45.11 |
1 | 173/19.46 |
2 | 214/24.07 |
3 | 77/8.66 |
≥ 4 | 24/2.70 |
Hospital admission | 103/11.59 |